结果患者出现门静脉血栓形成，肝栓塞坏死。
Results The patient was found to have destructive damage of portal vein.
结论门静脉血栓形成与持续性发热无明显相关性。
Conclusions There is no significant correlation between portal vein thrombosis and postoperative fever.
目的评价介入联合手术治疗门静脉血栓形成的疗效。
Objective to assess the efficacy and safety of intervention and surgical therapy of symptomatic portal venous thrombosis (PVT).
目的探讨脾切除术后门静脉血栓形成与持续发热的关系。
Objective to investigate the relationship between portal vein thrombosis and post-splenectomy fever in patients with portal hypertension.
发生肝动脉血栓形成和发生门静脉血栓形成的患者各发现一例。
Hepatic artery thrombosis and portal vein thrombosis were observed in one case each.
目的：研究和评价经皮治疗门静脉血栓技术的可行性和临床效果。
Purpose To study and evaluate the technique feasibility and clinical efficacy of percutaneous treatment for portal vein thrombosis(PVT).
目的探讨断流术后门静脉血栓形成与血小板膜蛋白cd 62p的关系。
Objective To investigate the relationship between the levels of platelets membrane glucoprotein CD62P with thrombosis of portal vein after devascularization operation.
目的探讨门静脉插管防治脾切除断流术后门静脉血栓形成的安全性和有效性。
Objective To investigate the safety and efficiency of portal vein catheterization for prevention and treatment of portal vein thrombosis after splenectomy and devasculation.
目的：探讨肝硬化、门脉高压症行脾切除术后早期应用抗凝药物对预防门静脉血栓的意义。
Objective To research the anticoagulants in protecting the portal vein obstruction after splenectomy due to the portal hypertension of hepatic cirrhosis.
材料与方法：16例有门静脉闭塞症状的患者，门静脉血栓均为非海绵状血管变性所致。
Materials and methods 16 patients who were evaluated for symptomatic portal occlusion, all patients with noncavernomatous PVT.
结果11例以非门静脉血栓形成的诊断入内科治疗，首诊为门静脉血栓形成44例入外科治疗。
Results 11 patients with no-first diagnosis of portal vein thrombosis into the medical treatment, first diagnosed 44 cases of portal vein thrombosis into the surgical treatment.
移出的肝脏出现皱缩，重量在715g到1199g（平均934g）.2名患者出现非阻塞性门静脉血栓。
Explanted livers were shrunken, with weights ranging from 715 to 1199 g (mean 934). Nonocclusive portal vein thrombosis was present in 2 patients.
《国际肝病》：本次会议在你主持的一节，有一个问题：门静脉血栓形成：抗凝治疗？是或否？您对此有什么看法？
Hepatology Digest: at a session you are moderating at this meeting, there is a question: Portal vein thrombosis: Anticoagulation? Yes or No? What is your opinion about that?
如果病人很可靠，并且没有其他抗凝治疗禁忌症，如果已分离出特定的门静脉血栓形成病人，那它就可以是最好的选择。
If the patient is very reliable and has no other contra-indications for anticoagulation, then it could be the best choice for that particular patient if they have isolated portal vein thrombosis.
结论：门静脉血栓形成是原发性肝癌切除术后一种少见的，但却是致命的血管并发症，其确切的发病机制、有效的预防及治疗方法需重视和进一步研究。
Conclusions: PVT is a rare but fatal vascular complication after liver resection for HCC. The precise mechanism, effective prevention and treatment need draw attention and further study.
结论：门静脉血栓形成是原发性肝癌切除术后一种少见的，但却是致命的血管并发症，其确切的发病机制、有效的预防及治疗方法需重视和进一步研究。
Conclusions: PVT is a rare but fatal vascular complication after liver resection for HCC. The precise mechanism, effective prevention and treatment need draw attention and further study.
应用推荐